The liquid-based MCED as a new screening paradigm (IMAGE)

Science China Press

The liquid-based MCED as a new screening paradigm

Caption

MCED is able to detect multiple cancer types by analyzing cfDNAs, cfRNAs, circulating proteins and metabolites using liquid-based biopsy techniques and AI algorithms. The TOO results of an MCED test provide further guidance for subsequent clinical diagnosis and treatment. This new screening paradigm will eventually reduce cancer-specific mortality and be recommended for a broader population. (Created with BioRender.com).

Credit

©Science China Press

Usage Restrictions

Use with credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.